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ABSTRACT
Background In the last few years, Malta has witnessed increasing immigration flows from the Libyan coasts. Public health policies are focused
on screening migrants for tuberculosis, whereas no systematic actions against STIs are implemented. The aim of this study is to define the
epidemiological profile of asylum seekers in Malta as regards syphilis, hepatitis B, C and latent tuberculosis, thus supporting screening policies.
Methods Five hundred migrants living in open centres were screened between December 2010 and June 2011.
Results 83.2% of people was from Somalia, 81.2% males, average age 26.5 years. The tuberculin skin test (TST) was positive in 225
migrants (45%). Latent syphilis was diagnosed in 11 migrants, hepatitis C in 3 and 31 migrants were HBsAg positive.
Conclusion Systematic screening for asymptomatic migrants in Malta is not recommended for hepatitis C and syphilis, given the low
prevalence observed. On the contrary, it should be considered for hepatitis B. TST could be indicated as the first step of a two step screening
for migrants from countries with high TB incidence. Efficacy and cost-effectiveness could be achieved by further targeting screening to specific
subgroups at higher risk of reactivation, such as people living with HIV and subjects affected by chronic diseases.
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Background
Inward migration to Southern European countries has
increased over the past years. Malta, situated in the middle
of the Mediterranean Sea, is constantly interested by massive
influxes of immigrants who leave poor African countries to
escape from social conflict, civil and political unrest and to
seek asylum in Europe.1 Malta has a total area of 316 km2
and about 404 000 inhabitants, resulting as the most densely
populated country in Europe. The phenomenon of ‘boat
migration’ began in 2001 and increased throughout the years
affecting local resources and the population. In 2010, the
number of migrants in Malta was estimated around 3000
individuals, with a predominance of people from the Horn
of Africa, followed by Western Africans and other national-
ities. The number of migrants continuously changes due to
new arrivals and departures of people who are resettled after
obtaining refugee status.
In this study, the term asylum seeker refers to migrants
with refugee status or humanitarian protection, and those
whose application was rejected or still pending.
Malta adopts administrative detention measures: upon
arrival, migrants can be detained for a maximum of 18
months. After release, they are generally accommodated in
one of the 10 open centres on the main island and grouped
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by age, marital status, gender and vulnerability conditions.
There are three largest open centres with a maximum cap-
acity of 800 people where serious problems concerning
living conditions, hygiene and lodging are usually reported.
The migrants hosted, who include a majority of young,
sexually active, single men, share a common room or tent
with a maximum of 25 persons. These conditions favour
the spreading of skin infections and communicable diseases.
Public health policies adopted in Detention and open
centres provide radiological screening for active and latent
TB only in case of pulmonary changes compatible with past
untreated disease. During the first days after arrival and
before release from detention, asylum seekers undergo chest
X-ray. In open centres, TB identification is based on passive
case finding and contact tracing. If affected by active pul-
monary TB, patients are started on treatment; preventive
treatment is offered to latent TB infection (LTBI)-positive
subjects.
TB prevalence in Malta is low (12/100 000).2
Nevertheless, migrants from countries with high TB endem-
icity3,4 are a risk group requiring targeted actions. No con-
sensus has been reached in Europe on the public health
impact of latent TB prevention in immigrants.5–7 Despite
this, also considering that a small percentage of migrants ar-
riving in Malta leaves the country within the following 5
years and that only some of them live in private accommo-
dations, TB infection screening and prevention represent an
important public health measure.
Contrary to the systematic approach adopted for TB, no
screening activities are provided for HIV/STIs among
asylum seekers. Few data are available on the incidence of
STIs in Malta8 and the numbers actually seen are undoubt-
edly underestimated. STIs are rather common in Africa.
Studies from the Horn of Africa, particularly Ethiopia,
report a HBsAg carriage rate between 5.4 and 15% and
anti-hepatitis C virus (HCV) positivity between 0.8 and
5.1% in the different groups considered.9,10 Therefore, the
arrival of asylum seekers may influence the prevalence of
STIs among the Maltese population, especially if no appro-
priate preventive programmes are planned.
A pilot study, aimed at assessing the prevalence of latent
TB, Hepatitis B and C, syphilis and abnormal liver function
in 500 asylum seekers hosted in the open centres was con-
ducted to provide data and support the development of
sound public health policies. The study was conducted in
the framework of the EU project ‘Mare Nostrum: Common
approach to upgrade asylum facilities in Italy and Malta’,
implemented by the National Institute for Health, Migration
and Poverty of Rome in partnership with Maltese health au-
thorities. According to the knowledge of the authors, this is
the first large-scale study on the epidemiological profile of
migrants in Malta.
Methods
Five hundred migrants hosted in Maltese Open Centres,
representing about one-sixth of the migrants in the country,
were recruited on a voluntary basis for 6 months from
December 2010 to June 2011. Screening was performed by
a team of doctors and cultural mediators in the three open
centres hosting higher numbers of migrants (500–800).
Under-18 people, pregnant women and migrants with past
history of treated latent or active TB were excluded from the
study. Screening was offered to migrants who had arrived in
Malta after 2007, with the aim of targeting migrants at
higher risk of TB reactivation and who would have benefited
more from screening and prophylactic treatment.5
A standardized, pre-coded questionnaire was administered
by a dermatologist and an infectious disease specialist sup-
ported by cultural mediators. A medical history focused on
socio-demographic data, particularly chronic liver diseases,
medications, alcohol consumption (type, quantity, duration
and mean daily intake), drug use, sexual health and possible
risk factors for Hepatitis B and C. Clinical examination for
assessing the presence of active TB was also performed.
Data were collected in a purpose-specific database; migrants
were registered with a double identification code corre-
sponding to the Identity Card (ID) number and a Police
number assigned by the immigration office upon arrival.
Diagnoses were recorded according to the International
Classification of Diseases (ICD-9).
A written multilingual informed consent was created with
the support of cultural mediators; contact details and tele-
phone numbers were collected in a separate file.
A tuberculin skin test (TST)—intradermal injection of
2-TU of PPD RT 23 (Statens Serum Institute, Copenhagen,
Denmark) on the volar aspect of the forearm—was per-
formed during the first examination as provided by standard
procedures.11 Induration was measured by palpation 72 h
later, and the TST was considered positive if the transverse
induration diameter was at least 10 mm. In the case of
HIV-positive patients or subjects with impaired immunity,
the cut-off point was set at 5 mm.11 TST-positive subjects
were referred for chest X-ray. Asymptomatic patients with
positive Mantoux test and chest X-ray abnormalities (fibro-
sis, mediastinal and/or hilar lymphadenopathy, signs com-
patible with inactive or past TB or apical fibronodular
diseases) were referred to the chest clinic for assessment and
interferon-g release assays (IGRA; Quantiferon TB Gold,
Cellestis, USA) in order to exclude active TB and further
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investigate for LTBI.12 Sputum of IGRA-positive migrants
was observed by direct microscopy and in culture for
Mycobacterium tuberculosis. Culture always resulted negative.
IGRA-positive migrants were therefore considered as LTBI
carriers and standard prophylactic treatment (INH þ RIF
for 3 months) was offered.
Blood samples for hepatitis, syphilis and liver chronic dis-
eases screening were collected in the open centres and pro-
cessed by a local private laboratory. All subjects were tested for
Hepatitis B surface antigen- HBsAg (method: ECLIA—
electrochemiluminescence immunoassay; cut-off index:
,0.90¼ negative; .0.902,1.0 ¼ borderline; .1.0 ¼ posi-
tive), HCV total antibodies (method: ELISA, enzyme-linked
immunosorbent assay; cut-off index: average negative control
þ 0.12, result issued positive or negative), aspartate amino-
transferase—AST (method: IFCC—International Federation
of Clinical Chemistry without pyridoxal phosphate; reference
range: males, 38 U/l, females, 32 U/l), alanine amino-
transferase—ALT (method: IFCC—International Federation
of Clinical Chemistry without pyridoxal phosphate; reference
range: males, 41 U/l, females, 31 U/l), VDRL—Venereal
Disease Research Laboratory /RPR—rapid plasma Reagin
(method: macroscopic non-treponemal flocculation test;
threshold : ,2 ¼ non reactive, .2 ¼ reactive) and TPHA—
treponema pallidum haemagglutination sssay (method : indir-
ect haemagglutination; threshold: ,80¼ negative, .80 ¼
positive).
Patients testing positive for one or more infections were
referred for treatment, follow-up and completion of STIs
screening to the Genito-Urinary Clinic at Boffa Hospital.
Patients with AST or ALT abnormalities testing negative for
hepatitis were further examined and referred for
confirmation.
The study was approved by the Maltese Ethic Committee.
‘Mare Nostrum’ project funds (ERF-European Refugees
Fund) covered the costs of laboratory tests for hepatitis,
syphilis and liver diseases screening; chest radiographies,
PPD-S and IGRA tests were provided by the Maltese
National Health Service.
Results
From December 2010 to June 2011, 500 migrants hosted in
Maltese Open Centres were screened for latent TB, hepatitis
B, C and syphilis. Among them, 83.2% (n ¼ 416) were from
Somalia, 8.2% (n ¼ 44) from Eritrea, 2.4% (n ¼ 12) from
Ethiopia and 5.6% (n ¼ 28) from West African countries.
81.2% (n ¼ 406) were males and the mean age was 26.5
years.
All subjects spent an average period of 5 months and a
half in a detention centre, and 9 months in an open centre.
As regards their legal status, 81.4% (n ¼ 407) had obtained
some form of international protection, whereas 9% (n ¼ 45)
of applications had been rejected. Only 0.4% (n ¼ 2) had
been recognized as refugees and in 9.2% of cases (n ¼ 46)
the application was still pending. 52.8% (n ¼ 264) declared
to be married and to have their family and children in the
origin country, 42% (n ¼ 210) were single, 3% (n ¼ 15)
divorced and 2.2% (n ¼ 11) widowed; as for religious
beliefs, 92% (n ¼ 460) declared to be Muslim, 7% (n ¼ 35)
Orthodox and 1% (n ¼ 5) Catholic. Only 9.6% (n ¼ 48)
declared they consumed tobacco, 2.4% (n ¼ 12) drugs, par-
ticularly khat, and 2.4% (n ¼ 12) alcohol. BCG vaccination
scars were observed in 18.6% (n ¼ 93) of the total sample.
According to STIs risk assessment, 96.8% (n ¼ 484) of
the considered subjects referred that they had less than five
sexual partners in their lifetime; 1.6% (n ¼ 8) persons
reported that they had an STI, 10% (n ¼ 50) declared that
they performed a HIV test at least once in their lives and
3.2% (n ¼ 16) they tested negative in the previous 6
months. 0.4% of men (n ¼ 2) reported having sex with
sexual workers in Malta.
Out of 94 women included in the study, 73.4% (n ¼ 69)
were from Somalia, 18% (n ¼ 17) from Eritrea, 7.4%
(n ¼ 7) from Ethiopia and 1% (n ¼ 1) from Nigeria;
35% (n ¼ 33) were single, 53% (n ¼ 50) married and 12%
(n ¼ 11) divorced. 96% (n ¼ 90) referred they had under-
gone some type of Female Genital Mutilation (FGM), half
of them had a type III FGM.
Table 1 Screening results in a sample of 500 migrants
Test Negative Positive Total
VDRL 491 (98.2%) 9 (1.8%) 500 (100%)
TPHA 489 (97.8%) 11 (2.2%) 500 (100%)
HBsAg 469 (93.8%) 31 (6.2%) 500 (100%)
HCVAb 497 (99.6%) 3 (0.6%) 500 (100%)
AST 450 (90%) 50 (10%) 500 (100%)
ALT 471 (94.2%) 29 (5.8%) 500 (100%)
IDR 252 (51.4%) 248 (49.6%) 500 (100%)
Latent syphilis was detected in 2.2% of migrants (VDRL negative/TPHA
positive or VDRL positive/TPHA negative; 72.7% males); HCV
antibodies were found in 0.6% (n ¼ 3) and 6.2% (n ¼ 31) resulted
HBsAg positive (93.5% males; 83.8% from Somalia; 67.7% in the age
group 20–30 years); 10% (n ¼ 50) had increased ALT levels (average
60 U/l) and 5.8% (n ¼ 29) raised AST levels (average 53.1 U/l). 49.6%
(n ¼ 248) were TST positive. The mean size of induration in
Mantoux-positive patients at 72 h was 17.3 mm.
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Screening results are reported in Table 1. Five hundred
and twenty-two migrants underwent a Manteaux test; out of
them, 22 (4.2%) did not attend follow-up visits and
dropped out of the study. Such a low rate of drop outs can
be explained with the particular setting where the study was
conducted, as all participants were hosted in reception
enters and tracking was easily performed.
Out of TST positive migrants, 214 (86%) underwent a
chest X-ray. Lung abnormalities, including fibrosis, fibro-
nodular changes, pleural thickness or pinching suspicious
for latent or past TB, were observed in 32 patients (14.9%);
they were referred to the Chest Clinic for follow-up and
possible IGRA testing. 19 (60%) of them resulted positive
to IGRA test and treatment was offered.
Discussion
Main findings of this study
The objective of this study was to define the epidemiology
of hepatitis B and C, syphilis and latent TB among asylum
seekers in Malta, to improve screening policies and to verify
the feasibility of systematic screening.
The sample was mainly composed of young men from
Sub Saharan Africa who had left Libya by boat after 2007.
Their majority had fled political persecution (Eritreans) and
war (Somali). Only a few of them had migrated for econom-
ic reasons, mainly from West Africa. Before arrival, many of
them had spent several years in transit countries, such as
Sudan or Libya. Differences in behavioural risk factors for
STIs were observed within the two groups, according to cul-
tural and religious beliefs. Most of them were Muslim; they
declared a very low number of sexual partners in their life-
time, not to use condom and to have austere sexual habits
due to religious restrictions. Most of people included in the
sample denied alcohol and recreational drug consumption,
except for khat, which is culturally acceptable in the Horn
of Africa. STI screening revealed low prevalence of HBsAg
carriage and latent syphilis, and very low prevalence of
hepatitis C antibodies, as expected on the basis of the self-
reported risk assessment and the target group’s ethnic
composition (Somali people with conservative sexual
habits and low behavioural risk for STIs). STIs-positive
migrants were referred to the Genitourinary Clinic and
further tested for HIV infection with negative results.
Other STIs such as chlamydia and gonorrhoea, which can
be asymptomatic, were not investigated. Clinical examin-
ation did not evidence other STIs. In the considered
sample, only a few migrants testing positive for hepatitis
had increased AST and ALT levels, thus suggesting, in
most cases, inactive carrier status; this result is in line with
findings of other authors.13,14
AST and ALT levels resulted abnormal in 70 patients
despite hepatitis markers were negative. Alcohol con-
sumption, drug abuse and food habits were investigated:
out of them, only three patients declared alcohol or
khat abuse. Oily food and drugs intake was put in relation
with transitory increase in liver enzymes. In particular,
khat chewing is being studied as possible cause of
hepatotoxicity.15,16
As regards latent TB screening, almost half of the sample
was TST positive and 32 people showed chest X-ray
changes, suggesting past or latent TB and therefore at
higher risk of reactivation. The study group had already
undergone radiographic TB screening upon arrival and just
before leaving Detention Centres. After this, healthy
migrants were moved to overcrowd open centres where 20
or more people shared the same living space, under condi-
tions of bad general hygiene and poor dietary intake, which
favour TB reactivation and susceptibility to infectious dis-
eases. It is also recognized that the risk of TB transmission
is higher within ethnic communities from high prevalence
countries.17 The above-mentioned factors may lead to new
infections and reactivation of latent TB acquired before
migration.18,19
What is already known on this topic
Screening was provided on a voluntary basis and the sample
was randomly recruited among healthy individuals corre-
sponding to the established selection criteria. The possibil-
ity to extend the same policy to the entire community is
debatable, both in terms of feasibility, ethics and cost-
effectiveness.20,21 A few recent studies on Somali migrants
showed substantial, even though not alarming, HBV circu-
lation in the general population and among migrant
groups in Europe, thus suggesting the possible usefulness
of applying preventive policies among this community.22
Two recent studies, which evaluated the cost-effectiveness
of adopting chronic hepatitis B screening policies for
migrants,23,24 showed that screening programmes, together
with provision of antiviral treatment to chronic infected
people, can be optimized by targeting specific ethnic
groups. This confirms the importance of considering
ethnic composition when planning surveillance and prevent-
ive measures.
As described in the literature, 50% of foreign-born TB
cases are diagnosed in the first 5 years after arrival in the
host country, then prevalence rapidly decreases over
time.25–27








alta user on 23 January 2020
National TB screening protocols for asylum seekers and
migrants entering Europe vary from country to country.
They are mostly aimed at screening for active TB and are
mainly based on chest radiography; nevertheless, little is
known about the efficacy and cost-effectiveness of these
policies. A recent analysis showed that radiographic screen-
ing has limited impact, is not cost-effective and requires
high levels of investment.28
No one-step, low cost, easy to administer and sensitive
screening test for LTBI exists which is specific enough to be
considered reliable without a confirmatory test. A TST is
usually used for LTBI screening but it has a number of lim-
itations, including high rates of cross-reactivity with BCG
vaccination and environmental non-tuberculous mycobac-
teria and possible influence on results due to operators’
bias.29
Chest radiography is useful for identifying LTBI cases
with increased risk of reactivation but, when used alone, this
screening tool reveals a high number of false-negative
results. More recently, IGRAs have been used as an alterna-
tive method for LTBI screening, but they require higher
costs and technical investment.
Studies showed that a limited number of migrants nor-
mally accept to undergo LTBI screening and prophylaxis
and that only 60% complete treatment.29 Optimization
could be reached by improving follow-up and treatment pro-
grammes and by targeting specific subgroups of migrants at
higher risk of reactivation (i.e. HIV-positive subjects, people
affected by chronic diseases or who had recent contact with
an active case).5,30
What this study adds
Based on the results of this study, systematic screening of
healthy asymptomatic asylum seekers recently arrived in
Malta results unsuitable for hepatitis C and syphilis, given the
low prevalence observed. On the contrary, systematic screen-
ing should be considered for hepatitis B, since early detection
and treatment of this infection substantially reduces liver-
related health outcomes. Systematic screening for chronic
HBV infection among migrants is likely to be cost-effective,
even estimating low HBV prevalence, participation, referral
and treatment compliance.23,31,32 Furthermore, early detec-
tion of HBsAg-positive subjects could have important public
health impact if preventive measures such as education and
vaccination of contacts and groups at risk are implemented.
As regards tuberculosis, optimization of screening proto-
cols is needed for increasing cost-effectiveness and reducing
unnecessary tests. A generalised use of TST for diagnosis of
latent infection appears to have low specificity and limited
effectiveness; it could be indicated as the first test of a
two-step screening for migrants from countries with high
TB incidence. Efficacy and cost-effectiveness can also be
achieved by targeting screening to specific subgroups at
higher risk of reactivation, such as people living with HIV,
subjects with radiographic changes compatible with past TB
and people affected by chronic diseases.
Limitations of this study
Due to the existence of ethnic, religious and cultural differ-
ences among migrant groups, which should be carefully
considered in the interpretation of results, the outcomes of
this study cannot be generalized. Other limitations include
the small sample size, its inhomogeneous ethnic compos-
ition, the exclusion of under-18 and the self-reporting of
sexual behaviours. Moreover, a direct link between ethnic
origin and epidemiological risk cannot be defined because
there is an increased exposure to infection in transit coun-
tries, during migrants’ movements within Europe and to
their native countries.33
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